Aurora Spine earned its fourth U.S. patent supporting its Dexa bone density matching technology, according to a May 7 news release.
U.S. Patent No. 12,605,252 B2 describes methods of btaining a patient’s bone density information, including a DEXA T-score or bone density measurement, choosing an implant having a density level matched to the patient and implanting devices.
“This fourth issued DEXA Technology patent represents another important milestone in Aurora Spine’s strategy to protect and expand our leadership in bone density-matched spinal implant innovation,” Trent Northcutt, Aurora Spine president and CEO said in the release. “DEXA Technology was created to address a real clinical challenge: patients do not all have the same bone quality. By giving surgeons implant options designed around bone density, we believe Aurora is advancing a more personalized and intelligent approach to spine surgery. Through the issuance of this patent, Aurora’s competitive position will improve and it support continued development of next-generation DEXA Technology-based implants across the Company’s spinal implant portfolio.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
